Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Immune Checkpoint Inhibitors Market | Page 2

Immune checkpoint inhibitor is gaining signifcant traction as an efcient therapy for cancer
treatment worldwide owing to less side efects, and targeted therapeutic efect. Therefore,
various pharmaceuticals, biotech companies, universities, and cancer centers are focusing on
investing in this segment. According to the Tufts Center for the Study of Drug Development
(CSDD) report, 2016, currently, over 130 biotech and 20 pharma companies are developing
immuno-oncology therapies, thereby fueling immune checkpoint inhibitors market growth in the
forecast period. Also, according to the New York-based, Cancer Research Institute (CRI), 2017,
currently 2,004 immuno-oncology agents including 940 in clinical stage and 1,064 in preclinical
stage are under development. Leading players are actively investing in research and
development in oncology treatment through various collaborations and individual research
studies, owing to benefts associated with immune-oncology therapies. Advent of innovative
immune-oncology therapies such as immune checkpoint inhibitors, have supported growth of the
market. For instance, in 2016, AbbVie and the University of Texas MD Anderson Cancer Center
entered into a three-year agreement for focusing on immune system’s complete potential to
fght against cancer.
Report includes chapters which deeply display the following deliverable about industry :
• Immune Checkpoint Inhibitors Market Research Objective and Assumption
• Immune Checkpoint Inhibitors Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Immune Checkpoint Inhibitors Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Immune Checkpoint Inhibitors Market, By Regions
• Immune Checkpoint Inhibitors Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Immune Checkpoint Inhibitors Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Immune Checkpoint Inhibitors Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Immune Checkpoint Inhibitors Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion